<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A panel of antibodies reactive in routinely fixed, paraffin-embedded tissue sections was compared with a panel of antibodies reactive in frozen sections for the immunophenotyping of cutaneous <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Three T cell-associated markers (UCHL1, MT-1, MT-2, six B cell-associated markers (MB-1, MB-2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-1, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-2, L-26, 4KB5), immunoglobulin heavy and light chains, anti-LCA antibody, two markers for Reed-Sternberg cells (Ber-H2, Leu-M1), one marker for macrophages (Mac-387) and anti-S-100 protein antibody were tested on <z:mpath ids='MPATH_458'>normal</z:mpath> skin, inflammatory <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin diseases</z:e>, and cutaneous <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphomas</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>On the basis of the results in frozen sections, 12 inflammatory T cell diseases, 14 T cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphomas</z:e>, and 10 B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphomas</z:e> were identified </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, two cases of specific skin infiltrates of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> have been examined </plain></SENT>
<SENT sid="4" pm="."><plain>Among T cell markers, the greatest sensitivity was exhibited by UCHL1, which stained <z:hpo ids='HP_0000001'>all</z:hpo> but one specimen of T cell infiltrate; it was negative in one specimen of <z:e sem="disease" ids="C0026948" disease_type="Neoplastic Process" abbrv="">mycosis fungoides</z:e> that progressed into a T-<z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The combined use of MB-2, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-2, and 4KB5 identified <z:hpo ids='HP_0000001'>all</z:hpo> B cell proliferations </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>-1 marked germinal centers in <z:hpo ids='HP_0000001'>all</z:hpo> cases of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphoma</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Ber-H2 stained the Reed-Sternberg cells in both cases of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and the large cells in the histiocytic type of <z:e sem="disease" ids="C0206182" disease_type="Neoplastic Process" abbrv="lyp">lymphomatoid papulosis</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Mac-387 and anti-S-100 protein antibody recognized macrophages and T-zone histiocytes (Langerhans cells and interdigitating cells), respectively </plain></SENT>
<SENT sid="9" pm="."><plain>A panel of antibodies reactive in routinely fixed, paraffin-embedded tissue sections is proposed that facilitates the identification of most B and T cell infiltrates in the skin </plain></SENT>
</text></document>